646 related articles for article (PubMed ID: 19822299)
21. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
[TBL] [Abstract][Full Text] [Related]
22. KIR genes and KIR ligands affect occurrence of acute GVHD after unrelated, 12/12 HLA matched, hematopoietic stem cell transplantation.
Ludajic K; Balavarca Y; Bickeböller H; Rosenmayr A; Fae I; Fischer GF; Kouba M; Pohlreich D; Kalhs P; Greinix HT
Bone Marrow Transplant; 2009 Jul; 44(2):97-103. PubMed ID: 19169284
[TBL] [Abstract][Full Text] [Related]
23. Impact of CD31 mismatches on the outcome of hematopoeitic stem cell transplant of HLA-identical sibling.
El-Chennawi FA; Kamel HA; Mosaad YM; El-Sherbini SM; El-Billey NA
Hematology; 2006 Aug; 11(4):227-34. PubMed ID: 17178660
[TBL] [Abstract][Full Text] [Related]
24. Tacrolimus instead of cyclosporine used for prophylaxis against graft-versus-host disease improves outcome after hematopoietic stem cell transplantation from unrelated donors, but not from HLA-identical sibling donors: a nationwide survey conducted in Japan.
Yanada M; Emi N; Naoe T; Sakamaki H; Takahashi S; Hirabayashi N; Hiraoka A; Kanda Y; Tanosaki R; Okamoto S; Iwato K; Atsuta Y; Hamajima N; Tanimoto M; Kato S
Bone Marrow Transplant; 2004 Aug; 34(4):331-7. PubMed ID: 15220958
[TBL] [Abstract][Full Text] [Related]
25. ABO blood group barrier in allogeneic bone marrow transplantation revisited.
Seebach JD; Stussi G; Passweg JR; Loberiza FR; Gajewski JL; Keating A; Goerner M; Rowlings PA; Tiberghien P; Elfenbein GJ; Gale RP; van Rood JJ; Reddy V; Gluckman E; Bolwell BJ; Klumpp TR; Horowitz MM; Ringdén O; Barrett AJ;
Biol Blood Marrow Transplant; 2005 Dec; 11(12):1006-13. PubMed ID: 16338623
[TBL] [Abstract][Full Text] [Related]
26. Impact of HLA-DPB1 allelic and single amino acid mismatches on HSCT.
Ludajic K; Balavarca Y; Bickeböller H; Pohlreich D; Kouba M; Dobrovolna M; Vrana M; Rosenmayr A; Fischer GF; Fae I; Kalhs P; Greinix HT
Br J Haematol; 2008 Jul; 142(3):436-43. PubMed ID: 18544086
[TBL] [Abstract][Full Text] [Related]
27. [Exploration of acute graft versus host disease and its risk factors after allo-hematopoietic stem cell transplantation].
Chen YH; Huang XJ; Guo NL; Ren HY; Zhang YC; Xu LP; Gao ZY; Lu DP
Zhonghua Xue Ye Xue Za Zhi; 2003 Feb; 24(2):61-3. PubMed ID: 12697096
[TBL] [Abstract][Full Text] [Related]
28. ABO-incompatible allogeneic hematopoietic stem cell transplantation following reduced-intensity conditioning: close association with transplant-associated microangiopathy.
Worel N; Greinix HT; Leitner G; Mitterbauer M; Rabitsch W; Rosenmayr A; Höcker P; Kalhs P
Transfus Apher Sci; 2007 Jun; 36(3):297-304. PubMed ID: 17569587
[TBL] [Abstract][Full Text] [Related]
29. [The prognostic analysis of KIR ligand mismatch in HLA-mismatched hematopoietic stem cell transplantation].
Zhao XY; Huang XJ; Liu KY; Xu LP; Liu DH
Zhonghua Xue Ye Xue Za Zhi; 2008 May; 29(5):316-20. PubMed ID: 18844069
[TBL] [Abstract][Full Text] [Related]
30. Partially matched related hematopoietic stem cell transplantation without ex vivo T cell depletion compared with matched unrelated transplantation in adult patients with hematologic malignancies.
Wang Y; Chen F; Han Y; Fu ZZ; Tang XW; Miao M; Qiu HY; Jin ZM; Sun AN; Wu DP
Biol Blood Marrow Transplant; 2009 Oct; 15(10):1258-64. PubMed ID: 19747633
[TBL] [Abstract][Full Text] [Related]
31. Outcome of haematopoietic stem cell transplantation in patients transplanted with matched unrelated donors vs allele-mismatched donors: a single centre study.
Hauzenberger D; Schaffer M; Ringdén O; Hassan Z; Omazic B; Mattsson J; Wikström AC; Remberger M
Tissue Antigens; 2008 Dec; 72(6):549-58. PubMed ID: 19000143
[TBL] [Abstract][Full Text] [Related]
32. Analysis of donor and recipient ABO incompatibility and antibody-associated complications after allogeneic stem cell transplantation with reduced-intensity conditioning.
Watz E; Remberger M; Ringden O; Lundahl J; Ljungman P; Mattsson J; Wikman A; Uhlin M
Biol Blood Marrow Transplant; 2014 Feb; 20(2):264-71. PubMed ID: 24274982
[TBL] [Abstract][Full Text] [Related]
33. Incidence, risks, and outcome of idiopathic pneumonia syndrome early after allogeneic hematopoietic stem cell transplantation.
Zhu KE; Hu JY; Zhang T; Chen J; Zhong J; Lu YH
Eur J Haematol; 2008 Dec; 81(6):461-6. PubMed ID: 18774951
[TBL] [Abstract][Full Text] [Related]
34. NOD2 polymorphisms predict severe acute graft-versus-host and treatment-related mortality in T-cell-depleted haematopoietic stem cell transplantation.
van der Velden WJ; Blijlevens NM; Maas FM; Schaap NP; Jansen JH; van der Reijden BA; Feuth T; Dolstra H; Donnelly JP
Bone Marrow Transplant; 2009 Aug; 44(4):243-8. PubMed ID: 19219079
[TBL] [Abstract][Full Text] [Related]
35. Prophylactic red blood cell exchange for prevention of severe immune hemolysis in minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation after reduced-intensity conditioning.
Worel N; Greinix HT; Supper V; Leitner G; Mitterbauer M; Rabitsch W; Fischer G; Rosenmayr A; Höcker P; Kalhs P
Transfusion; 2007 Aug; 47(8):1494-502. PubMed ID: 17655594
[TBL] [Abstract][Full Text] [Related]
36. Lack of effect of donor-recipient Rh mismatch on outcomes after allogeneic hematopoietic stem cell transplantation.
Wirk B; Klumpp TR; Ulicny J; Herman JH; Gajewski JL; Martin ME; Emmons RV; Mangan KF
Transfusion; 2008 Jan; 48(1):163-8. PubMed ID: 17900280
[TBL] [Abstract][Full Text] [Related]
37. Major ABO-incompatible hematopoietic stem cell transplantation: study of post-transplant pure red cell aplasia and endothelial cell chimerism.
Mueller RJ; Stussi G; Odermatt B; Halter J; Schanz U; Seebach JD
Xenotransplantation; 2006 Mar; 13(2):126-32. PubMed ID: 16623806
[TBL] [Abstract][Full Text] [Related]
38. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.
Liu QF; Fan ZP; Zhang Y; Jiang ZJ; Wang CY; Xu D; Sun J; Xiao Y; Tan H
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296
[TBL] [Abstract][Full Text] [Related]
39. Skin explant model of human graft-versus-host disease: prediction of clinical outcome and correlation with biological risk factors.
Wang XN; Collin M; Sviland L; Marshall S; Jackson G; Schulz U; Holler E; Karrer S; Greinix H; Elahi F; Hromadnikova I; Dickinson AM
Biol Blood Marrow Transplant; 2006 Feb; 12(2):152-9. PubMed ID: 16443513
[TBL] [Abstract][Full Text] [Related]
40. Risk factors for late infections after allogeneic hematopoietic stem cell transplantation from a matched related donor.
Robin M; Porcher R; De Castro Araujo R; de Latour RP; Devergie A; Rocha V; Larghero J; Adès L; Ribaud P; Mary JY; Socié G
Biol Blood Marrow Transplant; 2007 Nov; 13(11):1304-12. PubMed ID: 17950917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
